HIM
CALA

Hillsdale Investment Management’s Calithera Biosciences, Inc CALA Stock Holding History

Hillsdale Investment Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,050
Closed -$744K – 679
2020
Q2 		$744K Buy
+7,050
New +$837K 0.07% 247
2017
Q3 		– Sell
-560
Closed -$166K – 542
2017
Q2 		$166K Buy
+560
New +$150K 0.03% 291

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hillsdale Investment Management's CALA Position: Q3 2020 in Review

Hillsdale Investment Management sold out of Calithera Biosciences, Inc (CALA) in Q3 2020, closing a stake of 7,050 shares — an estimated $744K sold.

Hillsdale Investment Management first reported a position in CALA in Q2 2017 and held it in 2 quarters. The position peaked at $744K in Q2 2020. 97 funds tracked by Wall St. Rank hold CALA as of Q3 2020.

  • Hillsdale Investment Management reported no remaining Calithera Biosciences, Inc position as of Q3 2020 after selling out during the quarter.
  • Hillsdale Investment Management sold 7,050 Calithera Biosciences, Inc shares in Q3 2020, an estimated $744K.
  • Hillsdale Investment Management first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 2 quarters.
  • Hillsdale Investment Management's Calithera Biosciences, Inc position peaked at $744K in Q2 2020.
  • 97 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2020.

Based on Hillsdale Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.